Company intelligence / Profile preview

DeepCell Industries

Seattle, Washington, United States

Ownership: Private
Development stage: Other

Overview

DeepCell Industries was a Seattle-based biotechnology company that developed a proprietary technology platform for the infusion of cannabinoids into food products. Its flagship Crystal Fusion technology enabled the bonding of THC and CBD molecules directly to sugar and salt crystals, creating products such as Ruby Cannabis Sugar and Sapphire Cannabis Salt. The company aimed to provide a more consistent, bioavailable, and flavorless alternative to traditional cannabis edibles. While it successfully launched products in the Washington state recreational market, the company has since become inactive. It is distinct from the AI-driven single-cell analysis company Deepcell, Inc.

Therapeutic areas: PsychiatryNeurology
Modalities: Small molecule
Industry: Food & Nutrition

Beyond the preview

Go deeper on DeepCell Industries.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DeepCell Industries.

Explore the full profile